Clinical Trial Update: Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating bortezomib in patients with advanced myeloproliferative disorders has completed, including chronic myeloproliferative disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myeloproliferative Neoplasms

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Mayo Clinic | Conditions: Chronic Myeloproliferative Disorders, Leukemia | EARLY_Phase 1 | Status: COMPLETED